Skip to main content
editorial
. 2006 Dec 21;12(47):7568–7577. doi: 10.3748/wjg.v12.i47.7568

Figure 4.

Figure 4

Release of interle-ukin-1 receptor antagonist (IL-1ra) and IL-10 in the Adacolumn during Adacolumn GMA in patients with active ulcerative colitis. Column outflow returns to the patients. Elevated IL-1ra and IL-10 (both anti-inflammatory) in the column outflow is potentially very significant (see text for comments on IL-1ra and IL-10).